These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10968026)

  • 1. Practice patterns of some gynaecologists in Malaysia with regards to prophylactic oophorectomy and hormone replacement therapy.
    Ravindran J; Leow CH
    Med J Malaysia; 1996 Dec; 51(4):409-14. PubMed ID: 10968026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes of Italian gynaecologists towards prophylactic oophorectomy at hysterectomy for non-malignant conditions.
    Fuso L; Mazzola S; Ferrero A; Magistris A; Jacomuzzi ME; Carus AP; Dompè D; Marocco F; Logrippo V; Zola P
    Eur J Obstet Gynecol Reprod Biol; 2006 Jan; 124(1):82-7. PubMed ID: 16026916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scientific evidence changes prescribing practice--a comparison of the management of the climacteric and use of hormone replacement therapy among Swedish gynaecologists in 1996 and 2003.
    Thunell L; Milsom I; Schmidt J; Mattsson LA
    BJOG; 2006 Jan; 113(1):15-20. PubMed ID: 16398765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RANZCOG College Statement on prophylactic oophorectomy in older women undergoing hysterectomy for benign disease: is the evidence sufficient to change practice?
    Brand AH
    Aust N Z J Obstet Gynaecol; 2011 Aug; 51(4):296-300. PubMed ID: 21806570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prescription of hormone replacement therapy in Spain: differences between general practitioners and gynaecologists.
    Castelo-Branco C; Ferrer J; Palacios S; Cornago S
    Maturitas; 2006 Nov; 55(4):308-16. PubMed ID: 16730140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of ovarian cancer: a survey of the practice of prophylactic oophorectomy by consultant gynaecologists in Ireland.
    Geary M; Geoghegan A; Foley M
    Ir Med J; 1997; 90(5):186-7. PubMed ID: 9345830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicians and the prescription of hormone replacement therapy in Spain.
    Bermejo MJ; Pérez IR
    Health Policy; 2005 Jul; 73(1):58-65. PubMed ID: 15911057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of the practice of prophylactic oophorectomy by gynecologists in the state of Alaska.
    Conklin BH; McGuire PA; Weiler PL; Webb DI
    Alaska Med; 1996; 38(2):71-4. PubMed ID: 8712304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic oophorectomy in Northern Ireland.
    Fogarty P
    Ulster Med J; 1991 Oct; 60(2):172-5. PubMed ID: 1785152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current attitudes on self-use and prescription of hormone therapy among New York City gynaecologists.
    Devi G; Sugiguchi F; Pedersen AT; Abrassart D; Glodowski M; Nachtigall L
    Menopause Int; 2013 Sep; 19(3):121-6. PubMed ID: 23761315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting gynaecologists' decision to perform prophylactic oophorectomy concomitantly with hysterectomy: a Belgian survey.
    Plusquin C; Fastrez M; Vandromme J; Rozenberg S
    Maturitas; 2011 Dec; 70(4):391-4. PubMed ID: 22014472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis.
    Armstrong K; Schwartz JS; Randall T; Rubin SC; Weber B
    J Clin Oncol; 2004 Mar; 22(6):1045-54. PubMed ID: 14981106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone therapy prescription among physicians in France and Quebec.
    Ringa V; Légaré F; Dodin S; Norton J; Godin G; Bréart G
    Menopause; 2004; 11(1):89-97. PubMed ID: 14716188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Estonian and Finnish physicians' opinions of menopause and hormone therapy.
    Hovi SL; Karttunen T; Karro H; Hemminki E
    Maturitas; 2004 Oct; 49(2):107-13. PubMed ID: 15474754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of obstetrician-gynecologists concerning practice patterns and attitudes toward hormone therapy.
    Power ML; Zinberg S; Schulkin J
    Menopause; 2006; 13(3):434-41. PubMed ID: 16735940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy and malignant melanoma: to prescribe or not to prescribe?
    Durvasula R; Ahmed SM; Vashisht A; Studd JW
    Climacteric; 2002 Jun; 5(2):197-200. PubMed ID: 12051116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuation rate of hormone replacement therapy in Hong Kong public health sector.
    Leung KY; Ling M; Tang GW
    Maturitas; 2004 Dec; 49(4):338-44. PubMed ID: 15531131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women awaiting hysterectomy: a qualitative study of issues involved in decisions about oophorectomy.
    Bhavnani V; Clarke A
    BJOG; 2003 Feb; 110(2):168-74. PubMed ID: 12618161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [General practitioners' advice on hormone replacement therapy in menopause].
    Gjelsvik B
    Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1660-3. PubMed ID: 18704132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of ovarian cancer: a survey of the practice of prophylactic oophorectomy by fellows and members of the Royal College of Obstetricians and Gynaecologists.
    Jacobs I; Oram D
    Br J Obstet Gynaecol; 1989 May; 96(5):510-5. PubMed ID: 2757978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.